Olema Pharmaceuticals, Inc. OLMA Current ratio

Current ratio at other companies

Eli LillyLLY

1.4×+0.1×

LON

LeonaBio, Inc.LONA

10.4×+3.1×

Oric Pharmaceuticals, Inc.ORIC

16.3×+4.3×

Opko HealthOPK

3.3×-0.1×

Stoke Therapeutics, Inc.STOK

9×+0.6×

IDEAYA Biosciences, Inc.IDYA

10.7×-3.2×

FAQ

What is Olema Pharmaceuticals, Inc.'s current ratio?

Olema Pharmaceuticals, Inc. (OLMA) reported current ratio of 10.9× in Q1 2026.

How has Olema Pharmaceuticals, Inc.'s current ratio changed year-over-year?

Olema Pharmaceuticals, Inc.'s current ratio decreased by 28.5% year-over-year, from 15.2× to 10.9×.

What is the long-term trend for Olema Pharmaceuticals, Inc.'s current ratio?

Over 5 years (2020 to 2025), Olema Pharmaceuticals, Inc.'s current ratio has grown at a -33.2% compound annual growth rate (CAGR), from 74.6× to 10×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.